Hopewell Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Hopewell Therapeutics, Inc. - overview
Established
2018
Location
Woburn, MA, US
Primary Industry
Biotechnology
About
Based in Massachusetts, United States, and founded in 2018 by CEO Qiaobing Xu, Hopewell Therapeutics, Inc. , a. k. a.
Hopewell Therapeutics operates as a bio-tech company that utilizes differentiated lipid nanoparticle platform to harness unique ionizable lipid chemistry for to bring genomic medicines to patients. In May 2023, Hopewell Therapeutics raised USD 25 million in seed funding from 5Y Capital, Bopu Capital, Hike Capital, IMO Ventures, Mass Ave Capital and WS Investments. The company provides novel genomic medicines by designing systemically administered LNPs (lipid nanoparticles) to specifically target extrahepatic tissues and cells throughout the body. Hopewell Therapeutics is also targeting diseases of the lung to develop its internal pipeline, as well as exploring the potential of its tissue-targeted lipid nanoparticles (ttLNPs) platform for patients with unmet needs in oncology, neurological disorders, rare genetic diseases, and infectious diseases.
The company plans to use its proceeds from May 2023 funding to advance the development of genomic medicines based on its differentiated ttLNP platform through both internal pipeline programs and external partnerships.
Current Investors
5Y Capital, WS Investments, Hike Capital
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biotechnology, Bioinformatics
Website
www.hopewell-tx.com
Verticals
HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.